This week we interviewed Jason Kelly, CEO and Co-Founder of Ginkgo Bioworks, who will be giving a keynote talk at SynBioBeta SF 2017 on October 3rd. Ginkgo recently announced the creation of a new company with Bayer, with a $100M [...]
For years, the foundations of cancer treatment were chemotherapy, surgery, and radiation therapy. But over the past several years, progress with therapies that collect and use a patient’s own immune cells to attack tumors (in other words, immunotherapy) have greatly [...]
This week we interviewed Laura Adam, who will be speaking in the Computation and Synthetic Biology session (Sponsored by Amazon Web Services) at SynBioBeta SF 2017. She is an expert in the field of synthetic biology design automation and has [...]
The Molecular Assemblies story began more than 30 years ago when Dr. J. William Efcavitch and Curt Becker recognized the limitations of the chemical-based method of DNA synthesis. The process relies on harsh chemicals that both damage the DNA and [...]
Scientists have tried to mass-produce spider silk for decades with little success. As a naturally occurring supermaterial, spider silk is strong, extendible, lightweight, biodegradable, flexible, biocompatible, and can be processed into different formats, including 3D structures. Unlocking the secret to [...]
More and more companies are beginning to harvest animal products from cell cultures instead of animals themselves as a way to provide affordable and sustainable food to a growing population, while also tackling issues such as greenhouse gases emissions, overfishing [...]
Join our weekly synthetic biology newsletter:
